2 completed, 1 terminated, 1 withdrawn. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 2 |
Follow Blood Coagulation Disorder: new trials by email Literature Review of Blood Coagulation Disorder trials Research Report on Blood Coagulation Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) HMPL-523 - Immune Thrombocytopenia, Blood Platelet Disorder | Phase 1 | Withdrawn | Hutchmed | 2024-04-02 | 2025-09-16 | |
| Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors SPK-8016 - Adeno-Associated Virus (AAV), Blood Coagulation Disorder | Phase 1 / Phase 2 | Completed | Spark Therapeutics, Inc. | 4 | 2019-01-30 | 2024-02-23 |
| Dilutional Coagulopathy in Patients Undergoing Elective Surgery Fibrinogen - Blood Coagulation Disorder | Phase 1 / Phase 2 | Completed | Christian Fenger-Eriksen | 20 | 2007-06-01 | 2015-12-02 |
| Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements. Hemosense (PT/InR point of care device) - Blood Coagulation Disorder | Phase 1 | Terminated | University of Rochester | 200 | 2005-10-01 | 2015-04-27 |
Blood Coagulation Disorders (4) · Hematologic Diseases (2) · Hemorrhagic Disorders (2) · Autoimmune Diseases (1) · Blood Coagulation Disorders, Inherited (1) · Blood Platelet Disorders (1) · Coagulation Protein Disorders (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Hemophilia A (1) · Hemorrhage (1) · Immune System Diseases (1) · Pathologic Processes (1) · Purpura (1) · Purpura, Thrombocytopenic (1)
Hemic and Lymphatic Diseases (4) · Hematologic Diseases (2) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Cytopenia (1) · Embolism and Thrombosis (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Vascular Diseases (1)
Bulk Drugs (1) · Fibrinogen (1)
Christian Fenger-Eriksen (1) · Hutchmed (1) · Spark Therapeutics, Inc. (1) · University of Rochester (1)
United States (3) · Australia (1) · Denmark (1) · Germany (1) · Norway (1) · Spain (1)
Peter H Chang, D.O. (1) · Tiffany Chang, MD (1) · William Schelman, MD, PhD (1)